Showing results (51-60 of 991) with videos related to
Sort By:
Pageof 100
Drug Safety|October 1, 1996
The clinical implications of inhibition of the inducible form of cyclo-oxygenaseC Richardson, P EmeryBritish Journal of Rheumatology|February 1, 1986
A double-blind study of the simple analgesic nefopam in rheumatoid arthritisP Emery, T GibsonAnnals of the Rheumatic Diseases|November 1, 2011
Optimising treatment in rheumatoid arthritis: a review of potential biological markers of responseP Emery, T DörnerExpert Opinion on Pharmacotherapy|May 5, 2001
Leflunomide: a novel DMARD for the treatment of rheumatoid arthritisA Alldred, P EmeryClinical and Experimental Rheumatology|February 19, 2004
Role of biologics in early arthritisP Emery, Y SetoBMC Musculoskeletal Disorders|June 22, 2002
Long-term experience with implanted intrathecal drug administration systems for failed back syndrome and chronic mechanical low back painJ H Raphael, J L Southall, T V Gnanadurai, et al.International Angiology : a Journal of the International Union of Angiology|January 1, 1988
Complement activation in atherosclerosis: effect of angiography and surgeryA Kalos, A Germenis, P Prountzos, et al.Musculoskeletal Care|December 19, 2007
Measuring fatigue among women with Sjögren's syndrome or rheumatoid arthritis: a comparison of the Profile of Fatigue (ProF) and the Multidimensional Fatigue Inventory (MFI)C E Goodchild, G J Treharne, D A Booth, et al.Clinical and Experimental Immunology|July 1, 1991
Quantification of cross-reactive idiotype-positive rheumatoid factor produced in autoimmune rheumatic diseases. An indicator of clonality and B cell proliferative mechanismsF Shokri, R A Mageed, G D Kitas, et al.Pageof 100